Abstract
Pericytes surround capillaries in every organ of the human body. They are also present around the vasa vasorum, the small blood vessels that supply the walls of larger arteries and veins. The clinical interest in pericytes is rapidly growing, with the recognition of their crucial roles in controlling vascular function and possible therapeutic applications in regenerative medicine. Nonetheless, discrepancies in methods used to define, isolate, and expand pericytes are common and may affect reproducibility. Separating pure pericyte preparations from the continuum of perivascular mesenchymal cells is challenging. Moreover, variations in functional behavior and antigenic phenotype in response to environmental stimuli make it difficult to formulate an unequivocal definition of bona fide pericytes. Very few attempts were made to develop pericytes as a clinical-grade product. Therefore, this review is devoted to appraising current methodologies’ pros and cons and proposing standardization and harmonization improvements. We highlight the importance of developing upgraded protocols to create therapeutic pericyte products according to the regulatory guidelines for clinical manufacturing. Finally, we describe how integrating RNA-seq techniques with single-cell spatial analysis, and functional assays may help realize the full potential of pericytes in health, disease, and tissue repair.
Original language | English |
---|---|
Article number | 1095141 |
Journal | Frontiers in Cardiovascular Medicine |
Volume | 9 |
DOIs | |
Publication status | Published - 10 Jan 2023 |
Bibliographical note
Funding Information:This work was supported by grants from (i) the British Heart Foundation (PG/22//10843, Transferring healthy longevity gene to improve age-related heart dysfunction), (ii) Ph.D. scholarship from the Ministry of Higher Education of the Arabic Republic of Egypt (MM24/21, Pericyte tissue engineering for prevention of aortic aneurysm development and rupture), (iii) British Heart Foundation studentship (FS/16/64/32480, Derivation of swine pericytes to enable fit-for-purpose clinical translation), (iv) British Heart Foundation (grant PG/19/49/34440, A novel pericyte mechanism involving the transcriptional activator Nrf2), and (v) Heart Research UK translational project grant “Targeting pericytes for halting pulmonary hypertension in infants with congenital heart disease” (RG2697/21/23).
Publisher Copyright:
Copyright © 2023 Alvino, Mohammed, Gu and Madeddu.